Chinese biotech Brii Biosciences (HKEX: 2137) has licensed its experimental antibiotic BRII-693 to domestic pharma business ...

Theratechnologies, a Canada-based biopharma, is to be acquired by CB Biotechnology, an affiliate of Future Pak, a ...

Spanish gene therapy specialist VIVEbiotech has named Patricio Massera as its new president, bringing in a seasoned CDMO ...

Pharmaceutical companies are heading toward a steep patent cliff that could strip more than $230 billion in US drug sales ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

US pharma major Eli Lilly today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase III clinical trials ...

A new company is responsible for Japanese promotional activities for Actair, Stallergenes Greer’s sublingual immunotherapy ...

Multinational pharmaceutical companies (MNCs) are facing significant challenges in China's vaccine market, as regulatory ...

British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...